Alpine Woods Capital Investors LLC Sells 154,568 Shares of Kenvue Inc. $KVUE

Alpine Woods Capital Investors LLC lowered its position in Kenvue Inc. (NYSE:KVUE) by 56.9% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 117,254 shares of the company’s stock after selling 154,568 shares during the period. Alpine Woods Capital Investors LLC’s holdings in Kenvue were worth $1,903,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently bought and sold shares of KVUE. Trust Co. of Vermont boosted its holdings in Kenvue by 266.8% in the second quarter. Trust Co. of Vermont now owns 1,581 shares of the company’s stock worth $33,000 after acquiring an additional 1,150 shares in the last quarter. Truvestments Capital LLC purchased a new position in shares of Kenvue in the 1st quarter valued at approximately $37,000. Future Financial Wealth Managment LLC acquired a new stake in Kenvue in the 3rd quarter worth approximately $49,000. First Pacific Financial purchased a new stake in Kenvue during the 2nd quarter worth approximately $54,000. Finally, Ransom Advisory Ltd acquired a new position in Kenvue during the 1st quarter valued at approximately $56,000. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Insider Transactions at Kenvue

In related news, Director Jeffrey C. Smith purchased 3,200,000 shares of the company’s stock in a transaction that occurred on Friday, December 12th. The shares were purchased at an average price of $17.37 per share, with a total value of $55,584,000.00. Following the purchase, the director owned 27,307,632 shares of the company’s stock, valued at $474,333,567.84. The trade was a 13.27% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 1.68% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on KVUE shares. Redburn Partners set a $22.00 price objective on shares of Kenvue in a research note on Friday, September 26th. The Goldman Sachs Group dropped their price target on Kenvue from $22.00 to $19.00 and set a “neutral” rating on the stock in a research note on Thursday, October 2nd. Deutsche Bank Aktiengesellschaft set a $18.00 target price on Kenvue in a report on Friday, October 24th. Bank of America decreased their price objective on shares of Kenvue from $25.00 to $21.00 and set a “buy” rating for the company in a research note on Wednesday, October 8th. Finally, JPMorgan Chase & Co. dropped their price objective on shares of Kenvue from $24.00 to $21.00 and set an “overweight” rating on the stock in a report on Friday, October 10th. One equities research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and twelve have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Kenvue has a consensus rating of “Hold” and a consensus price target of $20.23.

Kenvue Price Performance

NYSE:KVUE opened at $17.11 on Thursday. The firm has a market cap of $32.78 billion, a price-to-earnings ratio of 22.81 and a beta of 0.60. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.98 and a quick ratio of 0.69. The company has a 50 day moving average price of $16.34 and a 200-day moving average price of $18.78. Kenvue Inc. has a 1-year low of $14.02 and a 1-year high of $25.17.

Kenvue (NYSE:KVUE) last posted its earnings results on Monday, November 3rd. The company reported $0.28 EPS for the quarter, beating analysts’ consensus estimates of $0.27 by $0.01. The firm had revenue of $3.76 billion for the quarter, compared to analysts’ expectations of $3.83 billion. Kenvue had a return on equity of 20.02% and a net margin of 9.55%.The company’s quarterly revenue was down 3.5% on a year-over-year basis. During the same period last year, the firm earned $0.28 EPS. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. Equities research analysts forecast that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, November 26th. Stockholders of record on Wednesday, November 12th were given a dividend of $0.2075 per share. The ex-dividend date was Wednesday, November 12th. This represents a $0.83 dividend on an annualized basis and a dividend yield of 4.9%. Kenvue’s dividend payout ratio (DPR) is 110.67%.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.